Alternate Day Buprenorphine Administration, Phase IX - 14

Summary

The purpose of this study is to determine if four times a subjects' daily maintenance dose will hold for 120 hours without changes in agonist and antagonist effects.

Timeline

Start

1992-03

Primary completion

—

Completion

—

Drugs

Indications